CTTH insider buying
CTT PHARMACEUTICAL HOLDINGS, INC.
Every qualifying open-market purchase of CTTH reported to the SEC on Form 4, parsed directly from the filings and linked back to the source on EDGAR. No buying cluster — two or more distinct insiders inside a rolling window — has been detected in CTTH yet; if one forms, it appears here (and hits our alert subscribers in real time).
All notable open-market buys in CTTH
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Nov 4, 2026 | Director, CEO | 9,000 | $0.05 | $450.0 | SEC ↗ |
| Oct 26, 2026 | Director, CEO | 5,880 | $0.06 | $335.2 | SEC ↗ |
| Oct 15, 2026 | Director, CEO | 2,000 | $0.06 | $114.0 | SEC ↗ |
| Oct 6, 2026 | Director, CEO | 3,700 | $0.06 | $203.5 | SEC ↗ |
| Sep 28, 2026 | Director, CEO | 3,400 | $0.06 | $187.0 | SEC ↗ |
| Sep 22, 2026 | Director, CEO | 10,100 | $0.05 | $454.5 | SEC ↗ |
| Sep 22, 2026 | Director, CEO | 10,100 | $0.05 | $454.5 | SEC ↗ |
| Sep 16, 2026 | Director, CEO | 10,900 | $0.05 | $523.2 | SEC ↗ |
| Sep 10, 2026 | CEO | 3,500 | $0.05 | $175.0 | SEC ↗ |
| Sep 4, 2026 | CEO | 9,800 | $0.05 | $479.2 | SEC ↗ |
| Sep 2, 2026 | CEO | 3,000 | $0.05 | $146.7 | SEC ↗ |
| Aug 31, 2026 | CEO | 3,500 | $0.05 | $171.5 | SEC ↗ |
| Aug 24, 2026 | CEO | 2,100 | $0.06 | $115.5 | SEC ↗ |
| Aug 20, 2026 | CEO | 11,500 | $0.05 | $517.5 | SEC ↗ |
| Aug 19, 2026 | CEO | 10,000 | $0.06 | $590.0 | SEC ↗ |
| Aug 14, 2026 | CEO | 1,800 | $0.06 | $111.6 | SEC ↗ |
| Aug 7, 2026 | CEO | 7,700 | $0.07 | $500.5 | SEC ↗ |
| Dec 17, 2025 | CEO | 8,300 | $0.06 | $498.0 | SEC ↗ |
| Nov 20, 2025 | Director | 200,000 | $0.04 | $8.0K | SEC ↗ |
| Nov 20, 2025 | CEO | 62,900 | $0.04 | $2.5K | SEC ↗ |
| Oct 31, 2025 | CEO | 7,000 | $0.06 | $420.0 | SEC ↗ |
| Sep 23, 2025 | CEO | 6,815 | $0.06 | $408.9 | SEC ↗ |
| Aug 2, 2025 | CEO | 44,085 | $0.05 | $2.2K | SEC ↗ |
| Aug 1, 2025 | CEO | 15,800 | $0.04 | $632.0 | SEC ↗ |
| Jul 8, 2025 | CEO | 8,000 | $0.03 | $240.0 | SEC ↗ |
CTTH insider buying — FAQ
- Are insiders buying CTTH stock?
- 2 insiders have bought CTTH (CTT PHARMACEUTICAL HOLDINGS, INC.) on the open market, most recently on Nov 6, 2026. No cluster buy — two or more distinct insiders within a rolling window — has been detected yet.
- How much CTTH stock have insiders bought?
- Insiders have bought a combined $35.1K of CTTH across 58 open-market purchases, based on SEC Form 4 filings.
- What is an insider cluster buy in CTTH?
- A cluster buy is two or more distinct CTT PHARMACEUTICAL HOLDINGS, INC. insiders — officers, directors, or 10% owners — each buying CTTH on the open market within a rolling window. None has been detected in CTTH yet.
- Where does this CTTH insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in CTTH
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy CTTH within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Transactions link to official filings; prices and market capitalizations may be cached market data. Read our methodology and data limits before interpreting the figures. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding CTTH.